Brief: Nexalis Therapeutics Seeks Trading Halt
22/05/2026 24:39
May 22 (Reuters) - Nexalis Therapeutics Ltd NX1.AX: TRADING HALT REQUESTED PENDING ANNOUNCEMENT ON EXISTING DEBT FUNDING FACILITY Further company coverage: NX1.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nexalis Therapeutics
See all newsBrief: Nexalis Therapeutics Says Sean Williams Has Resigned As Non-Executive Chairman
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval